A Comparison of 3 Tumor Markers (MIA, TA90IC, S100B) in Stage III Melanoma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparison of 3 Tumor Markers (MIA, TA90IC, S100B) in Stage III Melanoma Patients

Published:2007-01 Issue:5 Volume:25 Page:285-293
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Faries Mark B.,Gupta Rishab K.,Ye Xing,Lee Christopher,Yee Reynold,Leopoldo Zacharias,Essner Richard,Foshag Leland J.,Elashoff David,Morton Donald L.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900701208634

Reference35 articles.

1. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2. Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine

3. An Evidence-based Staging System for Cutaneous Melanoma

4. Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of S100 proteins and their functions in skin homeostasis, interface dermatitis conditions and other skin pathologies;Experimental Dermatology;2024-08

2. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases;Molecules;2022-10-06

3. Unraveling the Wide Spectrum of Melanoma Biomarkers;Diagnostics;2021-07-26

4. Diagnosis of Stage IV Melanoma;Cutaneous Melanoma;2020

5. Diagnosis of Stage IV Melanoma;Cutaneous Melanoma;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3